Verdinexor
- Generic Name
- Verdinexor
- Drug Type
- Small Molecule
- Chemical Formula
- C18H12F6N6O
- CAS Number
- 1392136-43-4
- Unique Ingredient Identifier
- 85Q03215IW
- Background
Kpt 335 is under investigation in clinical trial NCT02431364 (Trial of Safety and Tolerability of Oral Verdinexor (Verdinexor) in Healthy Adults).
Trial of Safety and Tolerability of Oral Verdinexor (KPT-335) in Healthy Adults
- First Posted Date
- 2015-05-01
- Last Posted Date
- 2023-01-20
- Lead Sponsor
- Karyopharm Therapeutics Inc
- Target Recruit Count
- 33
- Registration Number
- NCT02431364
- Locations
- 🇦🇺
Nucleus Network, Melbourne, Victoria, Australia
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath